1. Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers
- Author
-
Matan Hofree, Yuriy Kirichok, Trey Ideker, Amit J. Sabnis, Benjamin A Barad, Victor Olivas, Luping Lin, Charles H. Earnshaw, Philippe Gui, Nevan J. Krogan, Billy W. Newton, Asmin Tulpule, Manasi K. Mayekar, Elton Chan, Wei Wu, Evangelos Pazarentzos, Trever G. Bivona, Erik Verschueren, Jenny Jiacheng Yan, James S. Fraser, Saurabh Asthana, David V. Allegakoen, Nilanjana Chatterjee, John Von Dollen, William A. Weiss, Junji Suzuki, Gorjan Hrustanovic, Jeffrey R. Johnson, and Jennifer Flanagan
- Subjects
0301 basic medicine ,Male ,PTEN ,NKAP ,PDHK1 ,Medical Physiology ,Regulator ,Synthetic lethality ,Mice, SCID ,NF-κB ,Mice ,0302 clinical medicine ,Mice, Inbred NOD ,Neoplasms ,Pyruvate Dehydrogenase (Acetyl-Transferring) Kinase ,Tensin ,2.1 Biological and endogenous factors ,Aetiology ,lcsh:QH301-705.5 ,Tumor ,biology ,Chemistry ,NF-kappa B ,protein phosphatase ,Pyruvate dehydrogenase complex ,Female ,Signal transduction ,signaling ,Glycolysis ,Phosphatase ,SCID ,General Biochemistry, Genetics and Molecular Biology ,Article ,Cell Line ,03 medical and health sciences ,Rare Diseases ,Cell Line, Tumor ,Genetics ,Animals ,Humans ,cancer ,PTEN Phosphohydrolase ,Pyruvate Dehydrogenase Acetyl-Transferring Kinase ,synthetic lethality ,Brain Disorders ,Repressor Proteins ,030104 developmental biology ,HEK293 Cells ,lcsh:Biology (General) ,Anaerobic glycolysis ,Cancer research ,biology.protein ,Inbred NOD ,Biochemistry and Cell Biology ,metabolism ,030217 neurology & neurosurgery - Abstract
Summary: Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor suppressor and bi-functional lipid and protein phosphatase. We report that the metabolic regulator pyruvate dehydrogenase kinase1 (PDHK1) is a synthetic-essential gene in PTEN-deficient cancer and normal cells. The PTEN protein phosphatase dephosphorylates nuclear factor κB (NF-κB)-activating protein (NKAP) and limits NFκB activation to suppress expression of PDHK1, a NF-κB target gene. Loss of the PTEN protein phosphatase upregulates PDHK1 to induce aerobic glycolysis and PDHK1 cellular dependence. PTEN-deficient human tumors harbor increased PDHK1, a biomarker of decreased patient survival. This study uncovers a PTEN-regulated signaling pathway and reveals PDHK1 as a potential target in PTEN-deficient cancers. : The tumor suppressor PTEN is widely inactivated in cancers and tumor syndromes. Currently, there is no effective therapeutic strategy in the clinic for PTEN-deficient cancers. Chatterjee et al. found that PTEN-deficient cells and cancers are uniquely sensitive to PDHK1 inhibition and propose PDHK1 as a potential therapeutic target in PTEN-deficient cancers. Keywords: PTEN, protein phosphatase, PDHK1, NKAP, NF-κB, synthetic lethality, metabolism, signaling, cancer
- Published
- 2019